Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lupin Pharmaceuticals Inc, the US based wholly owned subsidiary of Lupin Limited, has received the US Food and Drug Administration (FDA) approval for the abbreviated new drug application (ANDA) of a generic version of Ortho McNeil's Levaquin (levofloxacin) tablets.
Subscribe to our email newsletter
Levaquin is a synthetic broad spectrum antibacterial agent used to treat or prevent infections caused by susceptible bacteria.
Lupin operates in Cardiovascular (prils and statins), Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAIDs, Anti-TB and Cephalosporins.